❤️Cardiovascular Health

An 8-amino acid endogenous peptide hormone central to the renin-angiotensin-aldosterone system (RAAS), mediating vasoconstriction, aldosterone release, and blood pressure regulation.

An endogenous peptide ligand for the APJ receptor involved in cardiovascular regulation, fluid homeostasis, angiogenesis, and energy metabolism, with therapeutic potential for heart failure.

A family of cardiac hormones that regulate blood pressure, fluid balance, and cardiac function — used clinically for heart failure diagnosis and treatment, and increasingly studied for cardioprotective benefits.

A synthetic heptapeptide derived from ACTH(4-10) with a Pro-Gly-Pro C-terminal extension, used as a nootropic and neuroprotectant with regulatory approval in Russia for stroke and cognitive disorders.

A 9-amino acid endogenous peptide hormone produced in the hypothalamus that regulates water retention, blood pressure, and social behavior through V1 and V2 receptor activation.

A mitochondria-derived 24-amino acid peptide with potent cytoprotective and neuroprotective effects, being studied for Alzheimer's disease, metabolic health, and longevity.

A naturally occurring nonapeptide that promotes delta-wave deep sleep, modulates stress hormones, and has potential applications in insomnia, pain, and withdrawal syndromes.

An FDA-approved GLP-1 receptor agonist used for type 2 diabetes and chronic weight management, producing significant weight loss of 15-17% body weight in clinical trials.

A synthetic heptapeptide anxiolytic derived from the endogenous immunomodulatory peptide tuftsin, with an added Pro-Gly-Pro C-terminus, approved in Russia for anxiety and neurasthenia.

The full-length 43-amino acid peptide from which TB-500 is derived, with comprehensive tissue repair, anti-inflammatory, and regenerative properties across virtually all tissue types.

A 28-amino acid neuropeptide with broad immunomodulatory, vasodilatory, and anti-inflammatory effects, used in CIRS (Chronic Inflammatory Response Syndrome) protocols and researched for pulmonary conditions.

A 15-amino acid synthetic peptide derived from human gastric juice that promotes healing of tendons, ligaments, muscles, gut lining, and other tissues through multiple regenerative pathways.

A first-in-class dual GIP/GLP-1 receptor agonist that produces up to 22.5% body weight loss, approved for type 2 diabetes and obesity management.

A class of molecules that boost cellular NAD+ levels to support energy metabolism, DNA repair, sirtuin activation, and anti-aging pathways — while not peptides themselves, they are commonly discussed alongside anti-aging peptides.

The arginine salt form of BPC-157, optimized for oral bioavailability and stability, used interchangeably with BPC-157 for tissue healing and gut repair.

An FDA-approved GLP-1 receptor agonist used for type 2 diabetes and obesity management, with cardiovascular and neuroprotective benefits.

An oral formulation of semaglutide co-formulated with the absorption enhancer SNAC, enabling GLP-1 receptor agonist therapy via daily tablet rather than weekly injection.

A 51-amino acid peptide hormone produced by pancreatic beta cells that regulates blood glucose, promotes nutrient uptake into cells, and is used medically for diabetes and off-label in bodybuilding as a powerful anabolic agent.

A first-in-class oral non-peptide GLP-1 receptor agonist in late-stage clinical development for obesity and type 2 diabetes, offering once-daily dosing without fasting requirements.

A 28-amino acid thymic peptide that modulates immune function, approved in multiple countries for hepatitis B and used as an immune enhancer in cancer and infectious disease.

A synthetic tetrapeptide based on the natural epithalamin peptide from the pineal gland, studied for its ability to activate telomerase and potentially slow cellular aging.

A mitochondria-targeted tetrapeptide that concentrates in the inner mitochondrial membrane, protecting cardiolipin and restoring bioenergetics in aging and disease.

A class of ultra-short (2-4 amino acid) tissue-specific peptides developed by Prof. Vladimir Khavinson that regulate gene expression in target organs, used in Russian medicine for anti-aging and organ-specific rejuvenation.

A 29-amino acid peptide hormone produced by pancreatic alpha cells that raises blood glucose, promotes fat breakdown, and is used medically for severe hypoglycemia emergencies and diagnostically for GI imaging.

A synthetic version of the naturally occurring 43-amino acid peptide Thymosin Beta-4, widely used for tissue repair, wound healing, reduced inflammation, and improved flexibility.

The oral formulation of BPC-157 using the arginate salt form, designed for convenient capsule administration targeting gut healing and systemic effects without injection.

An 11-amino acid synthetic peptide derived from erythropoietin (EPO) that promotes tissue repair and neuroprotection without stimulating red blood cell production.

The only human cathelicidin antimicrobial peptide, a 37-amino acid peptide beginning with two leucines, with broad-spectrum antimicrobial, anti-biofilm, immunomodulatory, and wound healing properties.

A 36-amino acid neuropeptide abundantly expressed in the brain and sympathetic nervous system that regulates appetite, stress resilience, anxiety, and energy homeostasis.

A 9-amino acid neuropeptide hormone involved in social bonding, trust, stress reduction, and sexual function, with emerging research in autism spectrum disorders and anxiety.

An experimental peptidomimetic that targets and destroys blood vessels supplying white adipose tissue, causing rapid fat loss through adipose tissue apoptosis in animal studies.